Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells

Journal of Virology

Volumn 70, Issue 10, 1996, Pages 7190-7197

  Fraefel, Cornel ^a   Song, Song ^a   Lim, Filip ^a,d   Lang, Phung ^a   Yu, Linda ^a   Wang, Yaming ^a   Wild, Peter ^c   Geller, Alfred I ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE;

ARTICLE; COSMID; DNA CLEAVAGE; DNA PACKAGING; EXPRESSION VECTOR; GENE TARGETING; HELPER VIRUS; HERPES SIMPLEX VIRUS 1; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 0029844849     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.10.7190-7197.1996     Document Type: Article

References (43)

1. Choi, D. W., M. Malucci-Gedde, and A. R. Kriegstein. 1987. Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7:357-368.
2. Cohen, J. I., and K. E. Seidel. 1993. Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc. Natl. Acad. Sci. USA 90:7376-7380.
3. Cunningham, C., and A. J. Davison. 1993. A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 197:116-124.
4. Dobson, A. T., T. P. Margolis, F. Sedarati, J. G. Stevens, and L. T. Feldman. 1990. A latent, nonpathogenic HSV-1-derived vector stably expresses β-galactosidase in mouse neurons. Neuron 5:353-360.
5. During, M. J., J. Naegele, K. O'Malley, and A. I. Geller. 1994. Long-term behavioral recovery in parkinsonian rats by an HSV-1 vector expressing tyrosine hydroxylase. Science 266:1399-1403.
6. Emson, P. C., S. Shoham, C. Feler, T. Buss, J. Price, and C. J. Wilson. 1990. The use of retroviral vector to identify foetal striatal neurones transplanted into the adult striatum. Exp. Brain Res. 79:427-430.
7. Everett, R. D., A. Cross, and A. Orr. 1993. A truncated form of herpes simplex virus type 1 immediate-early protein Vmw110 is expressed in a cell type dependent manner. Virology 197:751-756.
8. Federoff, H. J., M. D. Geschwind, A. I. Geller, and J. A. Kessler. 1992. Expression of ngf in vivo from a defective HSV-1 vector prevents effects of axotomy on sympathetic neurons. Proc. Natl. Acad. Sci. USA 89:1636-1640.
9. Ferrin, L. J., and R. D. Camerini-Otero. 1991. Selective cleavage of human DNA: recA-assisted restriction endonuclease (RARE) cleavage. Science 254:1494-1497.
10. Fraefel, C. Unpublished data.
11. Geller, A. I., and X. O. Breakefield. 1988. Defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons. Science 241: 1667-1669.
12. Geller, A. I., K. Keyomarski, J. Bryan, and A. B. Pardee. 1990. An efficient deletion mutant packaging system for defective HSV-1 vectors; potential applications to neuronal physiology and human gene therapy. Proc. Natl. Acad. Sci. USA 87:8950-8954.
13. Halbert, C. L., I. E. Alexander, G. M. Wolgamot, and A. D. Miller. 1995. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J. Virol. 69:1473-1479.
14. Heineman, T. C., and J. I. Cohen. 1994. Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro, J. Virol. 68:3317-3323.
15. Higuchi, R. 1989. Rapid, efficient DNA extraction for PCR from cells or blood. Amplifications 2:1-3.
16. Ho, D. Y., S. L. Fink, M. S. Lawrence, T. J. Meier, T. C. Saydam, R. Dash, and R. M. Sapolski. 1995. Herpes simplex virus vector system: analysis of its in vivo and in vitro cytopathic effects. J. Neurosci. Methods 57:205-215.
17. Ho, D. Y., and E. S. Mocarski. 1989. Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Proc. Natl. Acad. Sci. USA 86:7596-7600.
18. Ho, D. Y., E. S. Mocarski, and R. M. Sapolsky. 1993. Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Proc. Natl. Acad. Sci. USA 90:3655-3659.
19. Johnson, P. A., A. Miyanohara, F. Levine, T. Cahill, and T. Friedman. 1992. Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J. Virol. 66:2952-2965.
20. Johnson, P. A., K. Yoshida, F. H. Gage, and T. Friedman. 1992. Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector. Mol. Brain Res. 12:95-102.
21. Kalnins, A., K. Otto, U. Ruther, and B. Muller-Hill. 1983. Sequence of the lacZ gene of Escherichia coli. EMBO J. 2:593-597.
22. Kaplitt, M. G., P. Leone, R. J. Samulski, X. Xiao, D. W. Pfaff, K. O'Malley, and M. J. During. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:148-154.
23. Le Gal La Salle, G., J. J. Robert, S. Berrard, V. Ridoux, L. D. Stratford-Perricaudet, M. Perricaudet, and J. Mallet. 1993. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259:988-990.
24. Lim, F., D. Hartley, P. Starr, P. Lang, S. Song, L. Yu, Y. Wang, and A. I. Geller. Packaging defective HSV-1 vectors using an IE2 deletion mutant supports efficient expression in cultured cortical cells. BioTechniques, in press.
25. Mann, R., R. L. Mulligan, and D. Baltimore. 1983. Construction of retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33:153-159.
26. Mavromara-Nazos, P., and B. Roizman. 1989. Activation of herpes simplex virus 1 γ2 genes by viral DNA replication. Virology 161:593-598.
27. McCarthy, A. M., L. McMahan, and P. A. Schaffer. 1989. Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J. Virol. 63:18-27.
28. McGeoch, D. J., M. A. Dalrymple, A. J. Davison, A. Dolan, M. C. Frame, D. McNab, L. J. Perry, J. E. Scott, and P. Taylor. 1988. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69:1531-1574.
29. Paxinos, G., and C. Watson. 1986. The rat brain in stereotaxic coordinates. Academic Press, Sidney, Australia.
30. Richardson, J. H., J. F. Kaye, L. A. Child, and A. M. L. Lever. 1995. Helper virus-free transfer of human immunodeficiency virus type 1 vectors. J. Gen. Virol. 76:691-696.
31. Samulski, R. J., L.-S. Chang, and T. Shenk. 1989. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:3822-3828.
32. Schrag, J. D., B. V. Prasad, F. J. Rixon, and W. Chui. 1989. Three-dimensional structure of the HSV1 nucleocapsid. Cell 56:651-660.
33. Smith, I. L., M. A. Hardwicke, and R. M. Sandri-Goldin. 1992. Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology 186:74-86.
34. Song, S. Unpublished data.
35. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
36. Spaete, R. R., and N. Frenkel. 1982. The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector. Cell 30:295-304.
37. Starr, P., F. Lim, F. D. Grant, L. Trask, P. Lang, L. Yu, and A. I. Geller. Long-term persistence of defective HSV-1 vectors in the rat brain is demonstrated by reactivation of vector gene expression. Gene Ther., in press.
38. Stevens, J. G. 1975. Latent herpes simplex virus and the nervous system. Curr. Top. Microbiol. Immunol. 70:31-50.
39. Tomkinson, B., E. Robertson, R. Yalamanchili, R. Longnecker, and E. Kieff. 1993. Epstein-Barr virus recombinants from overlapping cosmid fragments. J. Virol. 67:7298-7306.
40. van Zijl, M., W. Quint, J. Briaire, T. de Rover, A. Gielkens, and A. Berns. 1988. Regeneration of herpesviruses from molecularly cloned subgenomic fragments. J. Virol. 62:2191-2195.
41. Wolfe, J. H., S. L. Deshmane, and N. W. Fraser. 1992. Herpesvirus vector gene transfer and expression of β-glucuronidase in the central nervous system of MPS VII mice. Nat. Genet. 1:379-384.
42. Wood, M. J. A., A. P. Byrnes, D. W. Pfaff, S. D. Rabkin, and H. M. Charlton. 1994. Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors. Gene Ther. 1:283-291.
43. Yang, Y., Q. Li, H. C. J. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.